CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $31,968,735
- in 3 filings, $32.0M under 10b5-1 plans
Net −$31,968,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-21 | Lin Yu-Hsin Chief Executive Officer | Other acquisition | +10,000 | 182,949 | ||
| 2026-04-21 | Scholl Hendrik Peter Chief Medical Officer | Other acquisition · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-04-21 | Chuang Hao-Yuan Chief Financial Officer | Other acquisition | +10,000 | 205,264 | ||
| 2026-04-21 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −64 | $163.49 | $10K | 12,602 |
| 2026-04-21 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −78 | $164.60 | $13K | 12,524 |
| 2026-04-21 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −332 | $165.49 | $55K | 12,192 |
| 2026-04-21 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −312 | $166.49 | $52K | 11,880 |
| 2026-04-21 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −214 | $167.34 | $36K | 11,666 |
| 2026-04-20 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −284 | $162.76 | $46K | 13,382 |
| 2026-04-20 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −524 | $163.52 | $86K | 12,858 |
| 2026-04-20 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −124 | $164.40 | $20K | 12,734 |
| 2026-04-20 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −40 | $165.29 | $7K | 12,694 |
| 2026-04-20 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −3 | $166.91 | $501 | 12,691 |
| 2026-04-20 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −16 | $167.17 | $3K | 12,675 |
| 2026-04-20 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −9 | $168.35 | $2K | 12,666 |
| 2026-04-17 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −32 | $158.46 | $5K | 14,634 |
| 2026-04-17 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −52 | $159.38 | $8K | 14,582 |
| 2026-04-17 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −226 | $160.55 | $36K | 14,356 |
| 2026-04-17 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −274 | $161.41 | $44K | 14,082 |
| 2026-04-17 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −216 | $162.48 | $35K | 13,866 |
Page 8 of 10 · 186 trades